...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The journal of clinical psychiatry >The Economic Burden of Schizophrenia in the United States in 2002.
【24h】

The Economic Burden of Schizophrenia in the United States in 2002.

机译：2002年美国精神分裂症的经济负担。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

OBJECTIVE: This study quantifies excess annual costs associated with schizophrenia patients in the United States in 2002 from a societal perspective. METHOD: Annual direct medical costs associated with schizophrenia were estimated separately for privately (N = 1090) and publicly (Medicaid; N = 14,074) insured patients based on administrative claims data, including a large private claims database and the California Medicaid program (MediCal) database, and compared separately to demographically/geographically matched control samples (1 case:3 controls). Medicare costs of patients over age 65 years were imputed using the Medicare/MediCal dual-eligible patients (N = 1491) and published statistics. Excess annual direct non-health care costs were estimated for law enforcement, homeless shelters, and research/training related to schizophrenia. Excess annual indirect costs were estimated for 4 components of productivity loss: unemployment, reduced workplace productivity, premature mortality from suicide, and family caregiving using a human capital approach based on market wages. All costs were adjusted to 2002 dollars using the Medical Care Consumer Price Index and were based on the reported prevalence in the National Comorbidity Survey Replication. RESULTS: The overall U.S. 2002 cost of schizophrenia was estimated to be Dollars 62.7 billion, with Dollars 22.7 billion excess direct health care cost (Dollars 7.0 billion outpatient, Dollars 5.0 billion drugs, Dollars 2.8 billion inpatient, Dollars 8.0 billion long-term care). The total direct non-health care excess costs, including living cost offsets, were estimated to be Dollars 7.6 billion. The total indirect excess costs were estimated to be Dollars 32.4 billion. CONCLUSION: Schizophrenia is a debilitating illness resulting in significant costs. The indirect excess cost due to unemployment is the largest component of overall schizophrenia excess annual costs.
机译：目的：本研究从社会角度量化了2002年美国精神分裂症患者的超额年度费用。方法：根据行政理赔数据（包括大型私人理赔数据库和加利福尼亚医疗补助计划（MediCal）），分别对私人（N = 1090）和公共（Medicaid; N = 14,074）被保险患者的精神分裂症相关的年度直接医疗费用进行了估算数据库，并分别与人口统计/地理位置匹配的对照样本（1个案例：3个对照）进行比较。使用符合Medicare / MediCal双重资格的患者（N = 1491）估算65岁以上患者的Medicare费用，并发布统计数据。估计每年用于执法，无家可归者收容所以及与精神分裂症有关的研究/培训的直接非医疗保健费用过多。据估计，生产力损失的四个组成部分每年会产生过多的间接费用：失业，工作场所生产力下降，自杀过早死亡以及使用基于市场工资的人力资本方法进行家庭护理。所有费用均使用“医疗保健消费者价格指数”调整为2002年的美元，并且是根据“全国合并症调查复制”中报告的普遍性得出的。结果：美国2002年精神分裂症的总费用估计为627亿美元，直接医疗保健费用为227亿美元（门诊70亿美元，药品50亿美元，住院患者28亿美元，长期护理80亿美元） 。非医疗保健直接直接总成本（包括生活费用抵消）估计为76亿美元。间接超额费用总额估计为324亿美元。结论：精神分裂症是一种使人衰弱的疾病，导致高昂的费用。失业造成的间接超额成本是精神分裂症超额年度总成本的最大组成部分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号